imgimg
imgimg
img
img
imgimg
Home
Public Policy Institute
About Public Policy Institute
Research Areas
img
Featured Work
Latest News
Publications Archive
img
Event Highlights
img
Academy of Chinese Studies
Hong Kong Chronicles Institute
Media Centre
About Us
About Our Hong Kong Foundation
img
Benefactors
img
Our Governance
Our Hong Kong Foundation
img
Academy of Chinese Studies
img
Hong Kong Chronicles Institute
img
Advisory Members
img
The Management
Legal and Audit
Annual Reports
Careers
Contact Us
Donate Now
imgimgimgimgimgimgimg
Banner
VIDEO

【The 2025-26 Budget - Forecasts】3 Suggestions Achieve the Goal of Becoming An International Hub for Life and Health Technology

18 Feb 2025 (Tue)

The 2025-26 Budget is scheduled for release on 26 February. Kenny Shui, Vice President of Our Hong Kong Foundation and Executive Director of Public Policy Institute, shares his views regarding the development of life and health technology in Hong Kong.

He suggest that the Greater Bay Area International Clinical Trial Institute should enhance collaboration with hospitals and research centers in other cities of the GBA. Additionally, the government should be more actively collaborate with the National Medical Products Administration (NMPA) , ensure that new drugs can enter the GBA market more swiftly.

As for the "Office for Attracting Strategic Enterprises"(OASES) which are full operation in 2022, he believes that the office attract more large biotech companies to establish in Hong Kong by implementing tax incentives and favorable land policies.


The 2025-26 Budget is scheduled for release on 26 February. Kenny Shui, Vice President of Our Hong Kong Foundation and Executive Director of Public Policy Institute, shares his views regarding the development of life and health technology in Hong Kong.

He suggest that the Greater Bay Area International Clinical Trial Institute should enhance collaboration with hospitals and research centers in other cities of the GBA. Additionally, the government should be more actively collaborate with the National Medical Products Administration (NMPA) , ensure that new drugs can enter the GBA market more swiftly.

As for the "Office for Attracting Strategic Enterprises"(OASES) which are full operation in 2022, he believes that the office attract more large biotech companies to establish in Hong Kong by implementing tax incentives and favorable land policies.

Support Us
Donate Now
Contact us
img
19/F Nan Fung Tower, 88 Connaught Road Central, Hong Kong
img
+852 2603 3001
Follow us on
imgimgimgimg
imgimgimg
ESG Care Organization
© Our Hong Kong Foundation Limited. All Rights Reserved.
Support Us
Donate Now
Contact us
19/F Nan Fung Tower, 88 Connaught Road Central, Hong Kong
Follow us on
imgimgimgimg
imgimgimg
ESG

© Our Hong Kong Foundation Limited. All Rights Reserved.